about
Crystal structure of the Leishmania major phosphodiesterase LmjPDEB1 and insight into the design of the parasite-selective inhibitorsLeishmaniasis-HIV coinfection: current challengesFirst-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimonyFirst cases of cutaneous leishmaniasis caused by Leishmania (Viannia) naiffi infection in Surinam.Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Cutaneous Manifestations of Human and Murine LeishmaniasisFacial structure alterations and abnormalities of the paranasal sinuses on multidetector computed tomography scans of patients with treated mucosal leishmaniasis.Systemic therapy of New World cutaneous leishmaniasis: A case report and review article.Acute New World cutaneous leishmaniasis presenting as tuberculoid granulomatous dermatitis.A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis.A case of severe visceral leishmaniasis resulting from travel to Greece.Molecular epidemiology of imported cases of leishmaniasis in Australia from 2008 to 2014.Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guideIdentification of Leishmania spp. by molecular amplification and DNA sequencing analysis of a fragment of rRNA internal transcribed spacer 2.Molecular and Functional Characterization of ssDNA Aptamers that Specifically Bind Leishmania infantum PABPIndotecan (LMP400) and AM13-55: two novel indenoisoquinolines show potential for treating visceral leishmaniasis.Toll-like receptors and leishmaniasis.Probing elongating and branching β-D-galactosyltransferase activities in Leishmania parasites by making use of synthetic phosphoglycansImmunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials.Common skin infections in travelers.Treatment of cutaneous leishmaniasis in travelers 2009.Leishmaniasis: new insights from an old and neglected disease.Therapy of vector-borne protozoan infections in nonendemic settings.Intermediate/borderline disseminated cutaneous leishmaniasis.Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis.LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014.Treatment of imported New World cutaneous leishmaniasis in Germany.Myiasis in Travelers.Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment.American cutaneous leishmaniasis in infancy and childhood.An unclear, chronic nasal ulcer.Concurrent Chagas' disease and borderline disseminated cutaneous leishmaniasis: The role of amiodarone as an antitrypanosomatidae drug.The immune microenvironment in cutaneous leishmaniasis.Molecular Identification of Leishmania spp. in Sand Flies (Diptera: Psychodidae, Phlebotominae) From Ecuador.Case report: Successful treatment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomal amphothericin B in an immunocompromised traveler returning from Eritrea.Outbreak of Leishmania braziliensis Cutaneous Leishmaniasis, Saül, French Guiana.Cutaneous leishmaniasis in a Japanese returnee from West Africa successfully treated with liposomal amphotericin B.Bite the hand that sprays you.Climate Change Contribution to the Emergence or Re-Emergence of Parasitic Diseases.
P2860
Q27648821-4ABA8D7D-B2C1-4266-9533-C7EBCE0B30E4Q28078359-7ED129D5-C5E7-4341-A08C-E1B283CF425CQ28475794-A4562AD7-6241-4D4C-A4F7-8E69EB9C7246Q29353858-F6886D96-4E01-46D6-9C20-46D6AF0F33C6Q30275257-AE507CB1-D3AF-4F4C-8628-604C38326D10Q33839048-0452F2E7-7618-4E52-993C-D25DEEAA2864Q33981782-5CC956C0-851A-4CFF-9B9C-E5520CE0ACD1Q34028355-2A352038-47E8-4703-87CA-1254E9452F89Q34124243-9312DEEB-EDEE-4B62-A589-EA6C0ADACFFAQ34422191-8321A160-8440-4F52-9FAF-5590E9DB6018Q34524442-E860D95D-86FA-41BC-8DF2-86CC4E15CB72Q35142845-FAE9643B-A4C3-47F5-BD57-C0DCD3246A04Q35160905-08086F7F-F4E5-4537-90BD-43DBB8D42F79Q35192158-DDF35107-967C-4395-82F8-390FEB228345Q35803273-C617A623-0A6D-49A5-B30A-49E4D60FE955Q36276947-C3DB7B50-743D-4C25-9584-3F33C2249409Q36483521-100C96D2-2FB1-4511-B8D1-891816C68E4BQ36860461-D9EA3B23-1743-4181-979B-E408BF3353C6Q37191345-BE594CA8-C8CD-4022-8DD0-6A4DA2B87CF6Q37230468-8D370500-B4FB-4417-B040-79A28C55E29FQ37428084-BF60653E-E4AD-498E-BED7-3E5D432BD300Q37870821-BCF43BCA-117C-4841-BFFD-B1BDB232F9ECQ37879203-B4148C1C-C6DE-4966-840C-902941BA8ACFQ38066602-B1763D2D-7AD2-4101-81DE-A96C5C02FD59Q38136837-B928F4B5-734C-4F2E-ADA0-2762971E5AF3Q38205451-1B4A3D42-6C26-4DD8-A0CC-57D94E345992Q39048632-EC62E378-F6B4-4161-A584-0F7C5A7E904BQ39155941-82CDE50B-52FC-413F-8B64-9E4862F50EBCQ39185984-630D79A6-881C-4AD4-967E-136A3FBCFB83Q39273435-D03ED070-4490-4B51-AE8E-D56F9FDEB0BEQ39336818-728CBF39-9510-45EF-A471-C9F006D357D0Q39507100-8BD0A996-A7BF-447C-BC39-FB4694BCC622Q41360414-2D0B816A-F31E-46CF-988A-31768C0F77C2Q41686429-A2115B19-6995-4B0E-BAB6-480B4E5C7490Q41990777-C76AB489-F8F2-4DD1-A5CB-90079EA0F755Q42156051-99B9063E-0E79-4EBA-B110-3287D6E60F1CQ42584794-76A6BC12-8D78-4D78-B692-E4C7C1493385Q43725878-1A45C4EB-4670-4DAC-9696-64DA34E0AF42Q44170629-758651FD-F1D2-4016-ADC8-36F729CC58BDQ47230115-7D9AB6E5-A998-4C7F-84E8-0D91A098ECB0
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
New world cutaneous leishmaniasis in travellers.
@ast
New world cutaneous leishmaniasis in travellers.
@en
type
label
New world cutaneous leishmaniasis in travellers.
@ast
New world cutaneous leishmaniasis in travellers.
@en
prefLabel
New world cutaneous leishmaniasis in travellers.
@ast
New world cutaneous leishmaniasis in travellers.
@en
P1476
New world cutaneous leishmaniasis in travellers.
@en
P2093
Cristoph Hatz
Johannes Blum
P304
P356
10.1016/S1473-3099(06)70492-3
P50
P577
2006-06-01T00:00:00Z